GV | Jotup

Visionary transitions from education to innovative technology, life sciences, and AI education

Retrieved on:

Mercredi, mai 8, 2024

They commended Visionary for its positive contributions to advancing science, technology, and education in Canada.

Key Points:

They commended Visionary for its positive contributions to advancing science, technology, and education in Canada.
They believe that Visionary will continue to provide more opportunities and contributions to the advancement of technology and innovation economy in Canada.
Faced with significant changes in Canadian education policies, which notably restricted international student visas and reshaped the education system, Visionary initiated a strategic transformation in September 2023.
Transitioning from traditional education to high technology, life sciences, and AI education, after over six months of efforts, we have successfully executed this strategic transformation objectives.

StrongDM Secures $34 Million Series C Funding to Expand into Europe and Asia, and Establish Zero Trust PAM for Enterprise Security

Retrieved on:

Jeudi, mai 2, 2024

GV, PAM, Policy, Sequoia Capital, StrongDM, Environment, Zero trust security model, Singtel, PALO, Series, Online shopping

PALO ALTO, Calif., May 2, 2024 /PRNewswire/ -- StrongDM, the Zero Trust privileged access company, today announced the closure of a $34 million Series C funding round led by Anchor Capital, with participation from new investors Capital One Ventures, Cisco Investments, Frontline Ventures, and Singtel Innov8, as well as existing investors including GV, Sequoia Capital, and True Ventures. This investment underscores StrongDM's commitment to reshaping enterprise security with its revolutionary Zero Trust privileged access management (PAM) solution. The Series C funding round brings StrongDM's total funding to $96 million.

Key Points:

This investment underscores StrongDM's commitment to reshaping enterprise security with its revolutionary Zero Trust privileged access management (PAM) solution .
The Series C funding round brings StrongDM's total funding to $96 million.
StrongDM introduces a next-generation PAM solution that shifts from traditional role- or attribute-based security models to one that emphasizes continuous, fine-grained, and context-aware policy enforcement.
Tim Prendergast, chief executive officer of StrongDM, emphasizes the transformative nature of its Zero Trust PAM solution: "Our Zero Trust approach extends beyond initial access, offering continuous protection throughout the entire session.

StrongDM Secures $34 Million Series C Funding to Expand into Europe and Asia, and Establish Zero Trust PAM for Enterprise Security

Retrieved on:

Jeudi, mai 2, 2024

GV, PAM, Policy, Sequoia Capital, StrongDM, Environment, Zero trust security model, Singtel, PALO, Series, Online shopping

PALO ALTO, Calif., May 2, 2024 /PRNewswire/ -- StrongDM, the Zero Trust privileged access company, today announced the closure of a $34 million Series C funding round led by Anchor Capital, with participation from new investors Capital One Ventures, Cisco Investments, Frontline Ventures, and Singtel Innov8, as well as existing investors including GV, Sequoia Capital, and True Ventures. This investment underscores StrongDM's commitment to reshaping enterprise security with its revolutionary Zero Trust privileged access management (PAM) solution. The Series C funding round brings StrongDM's total funding to $96 million.

Key Points:

This investment underscores StrongDM's commitment to reshaping enterprise security with its revolutionary Zero Trust privileged access management (PAM) solution .
The Series C funding round brings StrongDM's total funding to $96 million.
StrongDM introduces a next-generation PAM solution that shifts from traditional role- or attribute-based security models to one that emphasizes continuous, fine-grained, and context-aware policy enforcement.
Tim Prendergast, chief executive officer of StrongDM, emphasizes the transformative nature of its Zero Trust PAM solution: "Our Zero Trust approach extends beyond initial access, offering continuous protection throughout the entire session.

Delphia Therapeutics Launches to Pioneer a New Field of Cancer Medicines: Activation Lethality

Retrieved on:

Jeudi, mai 2, 2024

Delphia Therapeutics, Inc. (Delphia), announced its launch today to pioneer a new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene overactivation.

Key Points:

Delphia Therapeutics, Inc. (Delphia), announced its launch today to pioneer a new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene overactivation.
“Our activation lethality platform offers the potential for new cancer medicines that are effective on their own while also combating the emergence of resistance to classic targeted therapies.
Delphia integrates tumor genetics, novel functional genomic approaches, and studies of inhibitor drug resistance to identify targets that drive activation lethality.
Through its activation lethality platform, Delphia is advancing a pipeline of first-in-class cancer medicines that aim to better control oncogenic pathways.

Metsera Launches to Lead the Next Generation of Medicines for Obesity and Metabolic Diseases

Retrieved on:

Jeudi, avril 18, 2024

Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, announced its launch today.

Key Points:

Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, announced its launch today.
“Metsera was purpose-built over the last two years to get ahead of the innovation curve in one of the largest and fastest growing markets in the history of biopharma,” said Clive Meanwell, chief executive officer of Metsera.
“We have assembled a portfolio of long-acting injectable and oral agents to address multiple next-generation weight loss goals.
“Through optimized combinations of injectable and oral peptides, we aim to establish a cycle of continuous and responsive innovation to address a growing worldwide obesity crisis.”

Visionary Holdings Inc. Announcement of Management Change

Retrieved on:

Mercredi, avril 24, 2024

GV, EMBA, Physics, Artificial intelligence, Nanyang Technological University, Bachelor of Science, MBA, The Company

Mr. Chen has over 27 years of experience in development, construction, and architectural management.

Key Points:

Mr. Chen has over 27 years of experience in development, construction, and architectural management.
He has been serving as the President of Addington Development in Toronto, Canada since 2010.
Under his leadership, the company has successfully raised over $150 million CAD through various financings and improved construction processes, reducing costs by 15%.
Mr. Chen holds an Executive MBA (EMBA) from Nanyang Technological Institute in Singapore.

Alethea Raises $20M in Series B Funding for Disinformation Mitigation

Retrieved on:

Mardi, avril 9, 2024

WASHINGTON and SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- Alethea , the leading technology company in disinformation detection and mitigation, announced the close of a $20M Series B funding round led by GV , with participation from Ballistic Ventures , who led Alethea's Series A funding in 2022.

Key Points:

WASHINGTON and SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- Alethea , the leading technology company in disinformation detection and mitigation, announced the close of a $20M Series B funding round led by GV , with participation from Ballistic Ventures , who led Alethea's Series A funding in 2022.
Alethea is the leading technology company in disinformation detection and mitigation.
Alethea was represented by outside counsel WilmerHale in the Series B transaction.
Visit the Alethea careers page for more information on open positions across data science, product, engineering, finance, operations, and marketing and sales.

Global Leading Metal Shaping Equipment Maker HSG Strengthens Business Expansion in India

Retrieved on:

Mardi, avril 9, 2024

GV, Acceleration, Chennai Trade Centre, Invention, Hall, 3D printing

CHENNAI, India, April 9, 2024 /PRNewswire/ -- HSG Laser, a global leader in metal shaping equipment, is intensifying its business expansion efforts in India.

Key Points:

CHENNAI, India, April 9, 2024 /PRNewswire/ -- HSG Laser, a global leader in metal shaping equipment, is intensifying its business expansion efforts in India.
For over ten years, HSG Laser has built up a strong presence in the Indian metal shaping equipment industry.
HSG Laser has established global research and development (R&D) institutions, including an R&D center in Japan, representing a frontrunner in the photonics industry.
It is poised to solidify its position as a global leader in the metal shaping industry.

Polar Signals Announces Strategic Milestones: Secures $10.8M in Funding, Expands Board, and Launches AI-Driven Performance Optimizations

Retrieved on:

Mardi, mars 12, 2024

Data Management, Security, Technology, Software, Networks, Artificial Intelligence, Cloud, Signal, Alpha, Vercel, GV, Denial-of-service attack, TLS, Spark Capital, Software engineering, Growth, Observability, Management

This financial achievement reflects the strong confidence investors and, crucially, customers have in Polar Signals’ vision and mission.

Key Points:

This financial achievement reflects the strong confidence investors and, crucially, customers have in Polar Signals’ vision and mission.
In addition to the financial boost, Polar Signals is announcing the strategic expansion of its board.
Polar Signals also shares that Vercel has chosen Polar Signals Cloud as their continuous profiling platform.
Lastly, a significant innovation from Polar Signals is the introduction of AI-driven Performance Optimizations.

Visionary Holdings Inc. Announces Board Change

Retrieved on:

Jeudi, avril 4, 2024

Canadian Pharmacists Journal, GV, Void coefficient, The Company, CHG, Kealey, Canada India Foundation, Public policy, Artificial intelligence, AECL, Pharmacist, University, Queen's University, Pharmacy, Pharmacy school, Kent State University, School

The Company's board of directors (the "Board") elected Mr. Marc Kealey as the Company's Vice Chairman of the Board of Directors and a member of the Board.

Key Points:

The Company's board of directors (the "Board") elected Mr. Marc Kealey as the Company's Vice Chairman of the Board of Directors and a member of the Board.
Mr. Kealey has served as the Chairman of the Board since November 2022 to June 2023.
The Board has determined that Mr. Kealey qualifies as an "Independent Director" within the meaning of Nasdaq Rule 5605.
Following Mr. Kealey's appointment, the Board of the Company is comprised of five (5) directors, including four (4) independent directors.